Short-term pain with Molina Healthcare, Gilead Sciences, and Express Scripts stocks could still turn into long-term gains.
Find out how expected policy changes have helped these four large-cap healthcare stocks outperform the market following the November election.
Judges have determined that the merger does little to improve competition among insurers.
The health insurer had a good quarter, but its future is uncertain due to antitrust concerns about its pending acquisition of an industry peer.
Healthy young adults weren't properly incentivized to get health insurance, dooming the Affordable Care Act to failure.
Higher premiums and less competition can't stand in the way of record Affordable Care Act enrollment. However, it may not matter.
Despite a few instances of profitability for insurers, Obamacare's long-term sustainability is still in question.
The results of a new study may surprise you.
If business doesn't improve, this provider of Blue Cross Blue Shield insurance could significantly cut its Affordable Care Act coverage.
Here's why Donald Trump's victory sent these stocks to the emergency room.